Clinical Trial Update: Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment [Phase 2]

View source ↗

Summary

This document reports the withdrawal of a Phase 2 clinical trial evaluating oral Nepadutant for infantile colic sponsored by the Menarini Group.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Colic

Drugs mentioned

• Nepadutant (nepadutant)

Snippet

Sponsor: Menarini Group | Conditions: Infantile Colic | Phase 2 | Status: WITHDRAWN